Stock Split History
Incyte stock split history picture
Incyte (INCY) has 2 splits in our Incyte stock split history database. The first split for INCY took place on November 10, 1997. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. INCY's second split took place on September 01, 2000. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Incyte splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the Incyte stock split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, presented on a split-history-adjusted basis factoring in the complete Incyte stock split history. Incyte split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/05/2010
End date: 04/03/2020
Start price/share: $14.60
End price/share: $78.59
Dividends collected/share: $0.00
Total return: 438.29%
Average Annual Total Return: 18.33%
Starting investment: $10,000.00
Ending investment: $53,845.44
Years: 10.00
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of patients with intermediate or high-risk myelofibrosis, for the treatment of patients with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. Co. has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia. According to our Incyte stock split history records, Incyte has had 2 splits.
Date Ratio
11/10/19972 for 1
09/01/20002 for 1
INCY is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

INFI Split History
INO Split History
INSY Split History
INVA Split History
IPCI Split History
IRWD Split History
ISRG Split History
ITUS Split History
IVC Split History
JAGX Split History

Also explore: INCY shares outstanding history

Chanticleer Holdings, Inc. (BURG)
Ekso Bionics Holdings, Inc. (EKSO)
Mid-Con Energy Partners, LP (MCEP)
U.S. Gold Corp. (USAU)
InfraCap MLP ETF (AMZA)
Direxion Daily Latin America Bull 3X Shares (LBJ)
Direxion Daily MSCI Mexico Bull 3X Shares (MEXX)
Direxion Daily Natural Gas Related Bear 3X Shares (GASX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3X Shares (DRIP)
SUMR Brands (SUMR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Incyte
Incyte Insider Buying

Incyte Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.